Clin2
NCT04245436Possibly a fitRecruiting

Testing antidepressants for teens with anxiety

AnxietyDepressive Symptoms

Treatments studied

Part of Mental health clinical trials.

This trial studies whether an antidepressant can help teens (ages 12–17) with anxiety disorders such as generalized, social, separation, or panic anxiety. It looks at both early and longer-term success of treatment, while monitoring safety closely with a caregiver.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
60 people
Ages
12 years to 17 years
Study type
Interventional

Who can take part

  • You (and your parent/guardian) must be able to read and speak English well enough to participate
  • You must be 12 to 17 years old at the start of screening
  • You must have an anxiety disorder as the main diagnosis (generalized, social, separation, and/or panic), confirmed by a structured interview
  • A caregiver must agree to help with safety monitoring and sharing information with the study team
  • If you can become pregnant: you must have a negative pregnancy test and use an approved birth control method during the study and for at least 30 days after
  • You must have a negative drug test and be able to swallow capsules

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04623099Recruiting· Phase 4
Personalized escitalopram dosing for anxious teens

This study tests whether a genetics-guided approach to choosing and adjusting escitalopram (an anxiety medicine) can improve safety and effectiveness for anxious teens. It also checks that participants have certain anxiety severity scores and can safely take the study medication.

Cincinnati, Ohio
NCT06081348Recruiting· Phase 2
Sertraline vs. placebo for anxiety in kids with developmental disorders

This trial compares sertraline (a common antidepressant) to a placebo (a pill with no medicine) to see which better reduces anxiety in children and teens who also have a neurodevelopmental disorder like autism, ADHD, or Tourette's. The goal is to help you and your child understand if this treatment might offer relief from anxiety.

Calgary, Alberta
NCT06977178Recruiting
Teen anxiety and substance use study

This study looks at how anxiety in young teens might lead to substance use later. It uses brain scans and stress tests to understand these pathways.

Chapel Hill, North Carolina
NCT04245748Recruiting· Phase 4
Finding the best order of treatments for anxious depression

This study tests which treatment sequence works best for people with anxiety conditions (generalized, social, separation) and/or panic, who also have significant depression/anxiety symptoms. It may help you find a more effective step-by-step plan and compare treatment orders.

Cincinnati, Ohio
NCT04221997Recruiting· Phase 4
Sertraline study for anxious children and teens

This trial tests whether sertraline (an anti-anxiety medicine) helps children and teens with generalized, separation, and/or social anxiety disorders. It also includes healthy children/teens for comparison so researchers can better understand safety and symptoms over time.

Cincinnati, Ohio
NCT05329441Recruiting
Testing an anti-depression medicine for threat-related brain changes in teens

This trial studies how fluoxetine or escitalopram (anti-depression medicines) may affect brain systems involved in feeling threatened and staying anxious when you have depression. It also uses brain scanning and blood tests to measure these changes.

Los Angeles, California

Hear when a new Anxiety trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.